- Home
- HROW vs MLNK Comparison
HROW vs MLNK Comparison
Compare HROW & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- MLNK
- Stock Information
- Founded
- HROW 1998
- MLNK 1998
- Country
- HROW United States
- MLNK United States
- Employees
- HROW N/A
- MLNK N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- MLNK Computer Software: Prepackaged Software
- Sector
- HROW Health Care
- MLNK Technology
- Exchange
- HROW Nasdaq
- MLNK Nasdaq
- Market Cap
- HROW 1.1B
- MLNK 1.3B
- IPO Year
- HROW N/A
- MLNK 2021
- Fundamental
- Price
- HROW $33.02
- MLNK $16.34
- Analyst Decision
- HROW Strong Buy
- MLNK Hold
- Analyst Count
- HROW 7
- MLNK 7
- Target Price
- HROW $61.83
- MLNK $20.64
- AVG Volume (30 Days)
- HROW 453.8K
- MLNK 191.5K
- Earning Date
- HROW 08-11-2025
- MLNK 08-11-2025
- Dividend Yield
- HROW N/A
- MLNK N/A
- EPS Growth
- HROW N/A
- MLNK N/A
- EPS
- HROW N/A
- MLNK N/A
- Revenue
- HROW $212,858,000.00
- MLNK $319,970,000.00
- Revenue This Year
- HROW $46.17
- MLNK $6.21
- Revenue Next Year
- HROW $39.97
- MLNK $5.66
- P/E Ratio
- HROW N/A
- MLNK N/A
- Revenue Growth
- HROW 53.49
- MLNK 5.15
- 52 Week Low
- HROW $20.85
- MLNK $15.49
- 52 Week High
- HROW $59.23
- MLNK $25.33
- Technical
- Relative Strength Index (RSI)
- HROW 48.64
- MLNK 49.51
- Support Level
- HROW $30.12
- MLNK $15.55
- Resistance Level
- HROW $33.90
- MLNK $17.01
- Average True Range (ATR)
- HROW 1.70
- MLNK 0.38
- MACD
- HROW -0.50
- MLNK -0.03
- Stochastic Oscillator
- HROW 36.39
- MLNK 54.11
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About MLNK MeridianLink Inc.
MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.